¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immune deficiency disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • counterfeit disease
    ²Òº´
  • Cowden¡¯s disease
    Äڵ纴
  • creeping disease
    ±â´Âº´, ÆÄÇິ
  • Crohn¡¯s disease
    Å©·Ðº´
  • Crouzon¡¯s disease
    Å©·çÁ¾º´
  • Cushing¡¯s disease
    Äí½Ìº´
  • cystic kidney disease
    ³¶¼ºÄáÆÏº´, ³¶¼º½ÅÀ庴
  • cystine disease
    ½Ã½ºÆ¾º´
  • cystine storage disease
    ½Ã½ºÆ¾ÃàÀûº´
  • cytomegalic inclusion disease
    °Å´ë¼¼Æ÷Æ÷ÇÔº´, °Å´ë¼¼Æ÷ºÀÀÔüº´
  • cardiovascular disease
    ½É(Àå)Ç÷°üÁúȯ
  • Caroli disease
    Ä«·Ñ¸®º´
  • cat-scratch disease
    °í¾çÀÌÇÒÅ¡º´
  • celiac disease
    º¹°­º´, º¹°­Áúȯ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • cerebrovascular disease
    ³úÇ÷°üº´, ³úÇ÷°üÁúȯ
  • cervical disease
    Àڱøñº´, ÀڱðæºÎº´, ÀڱðæºÎÁúȯ
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • climatic disease
    ±âÈĺ´
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • cold hemagglutinin disease
    Àú¿ÂÇ÷±¸ÀÀÁý¼Òº´, ÇÑ·©ÀûÇ÷±¸ÀÀÁýº´
  • collagen disease
    ¾Æ±³Áúº´
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áõ, º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • immune phenomenon
    ¸é¿ªÇö»ó.
  • immune polysaccharides
    ¸é¿ª(¼º) ´Ù´ç·ù(¡­ÒýӨ׾).
  • immune precipitate
    ¸é¿ªÄ§°­¹°
  • immune protein
    ¸é¿ª´Ü¹éÁú.
  • immune reaction
    ¸é¿ª¹ÝÀÀ.
  • immune reactivity
    ¸é¿ª¹ÝÀÀ¼º.
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response
    ¸é¿ª¹ÝÀÀ
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • immune response, secondary
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡­Øóæ¹Úãëë).
  • secondary immune response
    ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£ó­îÜØóæ¹Úãëë).
  • secondary immune response
    ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£ó­îÜØóæ¹Úãëë).
  • soluble immune response suppressor
    °¡¿ë¼º ¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
  • treponema pallidum immune adherence test =tpia
    Æ®·¹Æ÷³×¸¶¸é¿ªºÎÂø½ÃÇè
  • zoster immune globulin
    ´ë»óÆ÷Áø ¸é¿ª ±Û·Îºí¸°
  • abdominal muscle deficiency syndrome
    º¹±Ù°á¼ÕÁõÈıº(ÜÙÐÉÌÀáßñøý¦ÏØ).
  • acid lipase deficiency
    »ê¼º ¸®ÆÄÁ¦ °áÇÌÁõ(ß«àõ¡­ÌÀù¹ñø)
  • adenosine,deficiency
    °áÇÌÁõ(ÌÀù¹ñø)
  • adrenocortical deficiency
    ºÎ½ÅÇÇÁú°áÇÌÁõ.
  • alimentary deficiency =dietary d.
    ½Ä»çºÎÁ·, ¿µ¾çºÎÁ·.
  • alpha antitrypsin deficiency panniculitis
    ¾ËÆÄ Çׯ®¸³½Å°áÇÌÁö¹æÃþ¿°
  • anemia iron deficiency
    ö°áÇ̼º ºóÇ÷.
  • anemia,folate deficiency
    ¿±»ê°áÇÌ(ç¨ß«ÌÀù¹)
  • anterior pituitary deficiency
    ³úÇϼöüÀü¿±±â´ÉºÎÀü(Áõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
IDM idiopathic disease of myocardium; immune defense mechanism; indirect method; infant of diabetic moth...
AMD acid maltase deficiency; acromandibular dysplasia; actinomycin D; adrenomyelodystrophy; age-related ...
APCD acquired prothrombin complex deficiency [syndrome]; adult polycystic kidney disease
LID large intraluminal density; late immunoglobulin deficiency; lymphocytic infiltrative disease
MEDAC multiple endocrine deficiency, Addison's disease, and candidiasis [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
cmd cartilage matrix deficiency
CED chronic energy deficiency
IGHD idiopathic growth hormone deficiency
IGD isolated gonadotrophin deficiency
SPD storage pool deficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blood disease
    Ç÷¾× ÀÌ»ó
    µ¿ÀǾî=hemic disease.
  • bone disease
    °ñ Áúȯ
    µ¿ÀǾî=osteo
  • Bowen's disease
    º¸À¢ º´, º¸À¢ Áúȯ
    1. À¯¿øÇüÀÇ °æ°è. ¼±¸íÇÑ Èë°¥»ö ³»Áö °¥»öÀÇ ±¹¼ÒÀû º´º¯À» Çü¼ºÇÑ´Ù. ±¸°­ Á¡¸·ÀÇ Àû»ö, ¹é»ö ¹ÝÁ¡À¸·Î ¶Ñ·ÇÇÑ ºÒ±ÔÄ¢ÇÑ ¼ºÀåÀ» ÇÑ´Ù. °¡Çǰ¡ µ¤È÷¸é¼­ ¿ø½É»óÀ¸·Î È®´ëÇϴµ¥ Ç¥ÇÇ ³»¾ÏÀÇ »óŸ¦ À¯ÁöÇÏ¸ç ±âÀúÃþ¿¡ ÆÄ±«, Áõ½Ä, ÀüÀ̸¦ ³ªÅ¸³»´Â °ÍÀº »ó´çÈ÷ ÁøÇàÇÑ °æ¿ìÀÌ´Ù. Ä¡·á¹ýÀ¸·Î¼­´Â ÀýÁ¦, Ç×¾ÏÁ¦ ¿¬°í°¡ »ç¿ëµÈ´Ù. 2. ³»Àå ¾Ï°ú °ü·Ã ÀÖ´Â ºñħÀ±¼º ¾ÏÁ¾À¸·Î µå¹°°Ô ¹ß»ýÇÏ¸ç ³²¼º, ¿©¼º ¸ðµÎ ¼º±â¿¡ ¹ß»ýÇÑ´Ù. 3. »óÇdz»ÀÇ ¾Ç¼º Á¾¾çÀÌ´Ù. ¾Ç¼º ¼ºÀåÀº °Ç°­ÇÑ ±âÀú¸·°ú ÇÔ²² »óÇÇ¿¡ Á¦ÇѵȴÙ. ÇǺδ ¸î °³ÀÇ À¶±âµÈ Á¡À» µ¿¹ÝÇÑ Ã¤ ºÓ°Ô ³ªÅ¸³ª¸ç ºÎºÐÀûÀ¸·Î Àμ³ÀÌ Çü¼ºµÇ¾î ÀÖ°í ºÎºÐÀûÀ¸·Î Á¥¾î ÀÖ´Ù. Áß¾Ó¿¡ À§ÃàÀ̳ª ±Ë¾çÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 4. ºñ±³Àû µå¹® ÁúȯÀ¸·Î ³ëÃâ ¶Ç´Â ºñ³ëÃâ ºÎÀ§¿¡ »ý±æ ¼ö ÀÖ´Ù. º´º¯Àº ÀÛ°í
  • Brill-Zinsser disease
    Brill-Zinsser º´
    ¹ßÁøÆ¼Çª½º¿¡ °É·È´ø ȯÀÚ¿¡¼­ ¹ß»ýµÇ´Â Àç¹ßÇüÀÇ º´À¸·Î ¸®ÄÉÄ¡¾Æ±ÕÀº º´ÀÌ ³ªÀº ÈÄ¿¡µµ ¼ö ½Ê³â°£ Áõ»ó ¾øÀÌ ¸²ÇÁÀý ¼Ó¿¡ Á¸¼ÓÇÒ ¼ö ÀÖ´Ù.
  • Buergers disease
    ¹ö°Å º´
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • bullous skin disease
    ¼öÆ÷¼º ÇǺΠÁúȯ
  • calcific mitral disease
    ¼®È¸È­ ½Â¸ðÆÇ¸· Áúȯ
  • caloric disease
    °í¿Â º´
    °í¿Â¿¡ ³ëÃâµÇ¾î ³ªÅ¸³ª´Â Áúȯ.
  • Canavan's disease
    Ä«³ª¹Ý º´
    »ó¿°»öü ¿­¼º À¯ÀüÇÏ´Â ÁúȯÀ¸·Î ¾Æ½ºÆÄ¸£Å侯½Ç¶óÁ¦
  • Castleman disease
    Castleman º´
    °Å´ë ¸²ÇÁÀý Áõ½Ä ¶Ç´Â ¸²ÇÁÀý °ú¿ÀÁ¾ µîÀ¸·Îµµ ºÒ¸®¿ì´Â ÀÌ ÁúȯÀº Çö¹Ì°æ ¼Ò°ß¿¡ µû¶ó À¯¸®Áú Ç÷°üÇü°ú ÇüÁú ¼¼Æ÷Çü µÎ À¯ÇüÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. À¯¸®Áú Ç÷°üÇüÀº ´Ù¾çÇÑ Å©±âÀÇ ¿©Æ÷·Î ±¸¼ºµÇ°í ÁÖÀ§¿¡ ¿ÜÅõÃþ ¸²ÇÁ±¸ÀÇ Áõ½ÄÀ¸·Î µ¿½É¿øÇüÀÇ ¹è¿­ÀÌ °üÂûµÈ´Ù. ¿©Æ÷ Áß½ÉÀº Ç÷°ü Áõ½Ä°ú Ç÷°ü º®ÀÇ À¯¸®Áú º¯È­·Î µÎ²¨¿öÁ® Hassall ¼Òü¿Í À¯»çÇÏ´Ù. ¿©Æ÷ »çÀÌ °£Áú Á¶Á÷¿¡´Â Ç÷°ü Áõ½Ä°ú ÇÔ²² ÇüÁú ¼¼Æ÷, ¸é¿ª¸ð¼¼Æ÷, È£»ê±¸°¡ ħÀ±ÇÑ´Ù. ÀÓ»óÀû Áõ»óÀÌ ¾øÀÌ ÇÑ °³ÀÇ Á¾±«·Î ³ªÅ¸³ª´Â °æ¿ì¿¡ 90% Á¤µµ°¡ ÃÊÀÚ¾ç Ç÷°üÇüÀ̰í Á¾°Ýµ¿¿¡ È£¹ßÇÏ¸ç ±×¹Û¿¡ °æºÎ, ¾×¿ÍºÎ, Àå°£¸· µî¿¡¼­ ³ªÅ¸³­´Ù. Ç÷Áú¼¼Æ÷ÇüÀº ´Ù¹ß¼ºÀ¸·Î ¿­, ºóÇ÷, ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡, ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Áõ°¡ µîÀÇ ÀÓ»ó Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü½ÅÀûÀÎ ÇüÁú¼¼Æ÷ÇüÀº ºñÁ¤»óÀûÀÎ °ú¸é¿ª ¹ÝÀÀÀ¸·Î ¿¹Èİ¡ ÁÁÁö ¾ÊÀ¸¸ç ¾Ç¼º ¸²ÇÁÁ¾À̳ª Ka
  • cat-scratch disease
    °í¾çÀÌ-ÇÒÅ¡ º´, ¹¦¼Òº´
    ÀÌ ÁúȯÀº ±Þ¼º °æ°ú¸¦ ÃëÇÏ¸ç °í¾çÀÌ¿Í Á¢ÃËÇÑ ¾ÆÀ̵é°ú ÀþÀºÀÌ¿¡°Ô¼­ °¡Àå ÈçÇÏ°Ô ¹ß»ýÇÑ´Ù. ÁÖ·Î ÇÒÄû°Å³ª ´Ù¸¥ »óó¸¦ ÅëÇØ¼­ ÀüÆÄµÇÁö¸¸, °ú°Å·ÂÀÌ ¾ø´Â °æ¿ìµµ ÀÖ´Ù. °í¾çÀÌ ÇÒÅ¡ º´Àº ±×¶÷ À½¼º °£»ó±ÕÀÎ Bartonella henselae¿¡ ÀÇÇØ¼­ ÀϾ´Ù. ÇÒÄý ´ÙÀ½ ¸çÄ¥ ÈÄ 1/3¿¡¼­ Á¢Á¾ À§Ä¡¿¡ ÀÏÂ÷Àû »óó°¡ ³ªÅ¸³­´Ù. ÀÌ °÷ÀÌ °¨¿°µÈ °÷À̸ç Áß¾Ó¿¡ ¾×Æ÷³ª ³óÆ÷°¡ ÀÖ´Â °¡Çǰ¡ µ¤Èù ±Ë¾çÀ̳ª ±¸ÁøÀ¸·Î ³ªÅ¸³­´Ù. 1-3ÁÖ ÈÄ¿¡ Àü¹ÝÀûÀÎ °¨¿°ÀÇ ¾ç»óÀÌ º¸ÀÌ¸ç ±¹¼ÒÀû Àӯļ±ÀÌ Àӯļ±¿°ÀÇ ±Ù°Å°¡ ¾øÀÌ Ä¿Áø´Ù. À̰ÍÀº ¾ÐÅëÀÌ ÀÖ°í °íÁ¤µÇ¾î ÀÖÀ¸¸ç ¿°ÁõÀÌ µÚµ¤°í ÀÖ´Ù. ȤÀº ´­·¯µµ ¾ÆÇÁÁö ¾ÊÀ¸¸ç °¥¶óÁø ¾ç»óÀ¸·Î ¿°Áõ ¾ç»ó¾øÀÌ º¸ÀÏ ¼öµµ ÀÖ´Ù. ³óÀÌ »ý±â´Â °ÍÀÌ ÈçÇϸç À̰ÍÀº ¹«±Õ¼º ³óÀÇ ¾ç»óÀÌ´Ù. ÁøÇà °úÁ¤ÀÌ ¾ç¼ºÀÏÁö¶óµµ ¾î¶² °æ¿ì¿£ ¿­ÀÌ ³ª¸ç ¸î ÁÖ µ¿¾È ½ÉÇÑ Àü½Å Áõ»óÀ» º¸À̱⵵ ÇÑ´Ù. ¸²ÇÁÀý Á¾´ë ½Ã¿¡´Â ¸²ÇÁÁ¾À̳ª ´Ù¸¥ ¾Ç¼º Á¾¾ç, °áÇÙ, ¸²ÇÁ À°¾ÆÁ¾, ±Þ¼º ¼¼±Õ¼º °¨¿°°ú °¨º°ÇØ¾ß ÇÑ´Ù.
  • celiac disease
    ¼Ò¾Æ ¸¸¼º ¼ÒÈ­Àå¾ÖÁõ, ¼Ò¾Æ Áö¹æº¯Áõ, º¹ºÎ Áúº´
    1. ½Äǰ ±Û·çÅÙ°ú °ü°è°¡ ÀÖÀ¸¸ç ¾Æ¸¶µµ ÀÌ ´Ü¹éÀÇ ±¸¼º ¼ººÐ¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀ¿¡ ÀÇÇÑ °Í °°´Ù. ¼ÒÀå À¶¸ðÀÇ ±¤¹üÀ§ÇÑ ½ÉÇÑ ¼Ò½Ç°ú ÇÔ²² Èí¼ö Ç¥¸éÀûÀÇ ½ÉÇÑ °¨¼Ò¸¦ Ư¡À¸·Î ÇÑ´Ù. º¸Åë ¼Ò¾Æ¿¡¼­ Ãʱ⿡ Áø´ÜÀÌ µÇÁö¸¸ ¼ö³â ´õ ´Ê°Ô ¹ß°ßµÇ±âµµ ÇÏ°í ¿©ÀÚ°¡ ³²ÀÚº¸´Ù ´õ ÈçÈ÷ ¹ß»ýÇϸç À¯Àü¼º¿¡ ÀÇÇÑ °ÍÀ̶ó »ý°¢µÈ´Ù. ¹«±Û·çÅÙ ½ÄÀÌ¿ä¹ýÀ» ÇÔÀ¸·Î¼­ Ä¡·á°¡ µÉ ¼ö ÀÖ´Ù´Â È®½ÇÇÑ ±Ù°Å°¡ ÀÖ´Ù. 2. 1889³â Gee´Â ¿µ¾ç ½ÇÁ¶Áõ, ºÒ·® ¼ÒÈ­º¯, º¹ºÎ ÆØ¸¸À» ÁÖ Áõ»óÀ¸·Î ÇÑ ¸¸¼º ÁúȯÀ» celiac º´À̶ó°í º¸°íÇß´Ù. ÀÓ»ó Áõ»óÀº ¼³»ç, º¹Åë, ±¸Åä µîÀÇ À§Àå Áõ»ó À̿ܿ¡ ºóÇ÷, »ö¼Ò Ä§Âø ÀÌ»ó, ´Ù¹ß¼º ½Å°æ¿°, ¼³¿°, °£, ºñÁ¾, ÀüÇØÁú ÀÌ»óÀ» ³ªÅ¸³½´Ù. È£¹ß ¿¬·ÉÀº À¯¾Æ±â¿Í Àå³â±âÀÌ´Ù. º´¸® ¼Ò°ßÀº ¼ÒÀåÀÇ Á¡¸· À¶¸ðÀÇ ¼öÃà ³»Áö ¼Ò½Ç, Á¡¸· °íÀ¯Ãþ¿¡ÀÇ ¸²ÇÁ±¸¿Í ÇüÁú ¼¼Æ÷ÀÇ Ä§À±À» ÀÎÁ¤ÇÒ ¼ö ÀÖ´Ù.
  • cerebral vascular disease
    ³ú Ç÷°ü Áúȯ
  • cervical degenerative joint disease
    ÅðÇ༺ °æ°üÀý Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
muscle phosphorylase deficiency Type V glycogen storage disease, affecting muscle, caused by deficiency of muscle phosphorylase.
(05 Mar 2000)
corpus luteum deficiency syndrome <syndrome> Functional disturbances caused by insufficient ovarian luteinization; reflected by inadequate luteal phase endometrial response.
(05 Mar 2000)
polyendocrine deficiency syndrome <syndrome> Polyglandular deficiency syndrome, associated pathologic dysfunction of several endocrine glands, as in Schmidt's syndrome.
(05 Mar 2000)
myophosphorylase deficiency glycogenosis Glycogenosis due to muscle glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in muscle.
Synonym: McArdle's disease, McArdle's syndrome, McArdle-Schmid-Pearson disease, myophosphorylase deficiency glycogenosis.
(05 Mar 2000)
potassium deficiency A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhoea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing polyuria and decreased maximal urinary concentrating ability with secondary polydipsia. (merck manual, 16th ed)
(12 Dec 1998)
hageman factor deficiency A deficiency of a specific blood clotting factor (XII) that may be genetic or acquired. Administration of heparin or severe liver disease may result in factor XII (Hageman factor) deficiency. There are usually no symptoms associated with this deficiency, but there may be symptoms of mild blood loss in some cases. Treatment is generally unnecessary. Individuals should be cautioned against the use of medications (for example aspirin, warfarin, heparin) with anticoagulant activity, due to risk of exaggerated effects.
(27 Sep 1997)
hepatophosphorylase deficiency glycogenosis Glycogenosis due to hepatic glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in liver and leukocytes.
Synonym: hepatophosphorylase deficiency glycogenosis, Hers' disease.
(05 Mar 2000)
protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
protein deficiency A nutritional condition produced by a deficiency of proteins in the diet, characterised by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization).
(12 Dec 1998)
protein s deficiency An autosomal dominant disorder showing decreased levels of plasma protein s antigen or activity, associated with venous thrombosis and pulmonary embolism. Protein s is a vitamin k-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated protein c (also a vitamin k-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein c deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis.
(12 Dec 1998)
prothrombin deficiency A congenital or acquired disorder of blood clotting where there is a deficiency of factor II (prothrombin), one of 20 necessary plasma proteins for normal blood coagulation. Acquired factor II deficiency may result from vitamin K deficiency, severe liver disease and anticoagulant drugs.
Symptoms include abnormal bleeding, nosebleeds, abnormal menstrual bleeding, easy bruising and umbilical cord bleeding at birth. Treatment involves the infusion of fresh frozen plasma. Vitamin K may be administered in select cases.
(27 Sep 1997)
proximal femoral focal deficiency A congenital defect in which variable portions of the upper end of the femur are reduced or absent.
(05 Mar 2000)
pseudocholinesterase deficiency An autosomal dominant disorder manifested by exaggerated responses to drugs ordinarily hydrolyzed by serum pseudocholinesterase (e.g., succinylcholine); believed to entail production of a variant enzyme that is less active than the normal enzyme in hydrolyzing appropriate substrates, but also abnormally resistant to the effects of anticholinesterases.
(05 Mar 2000)
secondary antibody deficiency Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
selective immunoglobulin A deficiency <immunology> An inherited disorder in which there is a markedly reduced or absent IgA, resulting in immature IgA-bearing B-cells.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á